This book, Chain Reactions: The hopeful history of uranium, appears to be about the chemistry and physics of element number 92 in the Periodic Table. However, it also covers an eclectic mix of topics, some with only a tenuous link to element 92. Uranium is frequently a springboard, for example, for dives into the turbulent waters of nuclear power politics; in particular, the role that nuclear energy could and should play in the long-term future of our world.
With all the AI hype on one side and the concern on the other, Richard Susskind’s guide provides a welcome voice of calm. Based on decades of experience, the author offers deeply thought analyses of the risks and benefits of AI.
Researchers in Japan have chemically modified Vitamin K to boost its neuron formation capabilities. This could act to replenish neurons lost in neurodegenerative diseases such as Alzheimer’s or Parkinson’s disease. The study synthesised 12 variants of Vitamin K compounds with side chain modifications
A new method to produce strong, biodegradable plastic from bamboo has been proposed by Chinese researchers. They say the bioplastic compares well with oil-based plastics in strength, processability, and thermal stability and can biodegrade in soil within 50 days.
Macroalgae – or seaweed – farming has taken off in recent years, spurring innovation. With 12,000 species spread around the world’s oceans, there’s a lot of untapped biomass ripe for harvesting. Katrina Megget reports
Researchers have looked at the possibility of using cellulose membranes fabricated from wastepaper to remove Fe(II) ions from mine wastewater.
Nigel P. Freestone from the University of Northampton summarises some of his selected research papers from recent journal issues for Issue 11 of C&I magazine.
The success of the cutting-edge CAR-T cancer treatment that involves transforming a patient’s immune cells so they can identify and destroy cancer cells has led to a broad range of developments and improvements. Future modifications promise hope for a wider range of cancers and other diseases.
A UK Government medicines manufacturing workforce scheme aiming to bridge a significant skills gap in the life sciences sector, has delivered ‘overwhelmingly positive’ first results.
Researchers have combined generative artificial intelligence (AI) and antibiotics data to help them seek out potential new forms of pesticides.